OEP Capital Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170M Hold
16,312,698
100% 1
2026
Q1
$194M Buy
16,312,698
+2,494,518
+18% +$25.5M 100% 1
2025
Q4
$138M Hold
13,818,180
100% 1
2025
Q3
$124M Hold
13,818,180
100% 1
2025
Q2
$130M Hold
13,818,180
100% 1
2025
Q1
$150M Hold
13,818,180
100% 1
2024
Q4
$132M Hold
13,818,180
100% 1
2024
Q3
$155M Hold
13,818,180
100% 1
2024
Q2
$138M Hold
13,818,180
99.29% 1
2024
Q1
$159M Hold
13,818,180
57.84% 1
2023
Q4
$101M Hold
13,818,180
20.83% 2
2023
Q3
$126M Hold
13,818,180
23.74% 2
2023
Q2
$168M Hold
13,818,180
17.43% 2
2023
Q1
$172M Hold
13,818,180
16.86% 2
2022
Q4
$266M Hold
13,818,180
28.11% 2
2022
Q3
$260M Hold
13,818,180
34.42% 2
2022
Q2
$249M Hold
13,818,180
34.74% 2
2022
Q1
$222M Hold
13,818,180
25.63% 2
2021
Q4
$338M Hold
13,818,180
29.22% 2
2021
Q3
$322M Hold
13,818,180
24.37% 2
2021
Q2
$379M Hold
13,818,180
30.43% 2
2021
Q1
$508M Hold
13,818,180
39.07% 2
2020
Q4
$519M Buy
+13,818,180
New +$427M 30.46% 2

Other funds holding AHCO

OEP Capital Advisors's AHCO Position: Q2 2026 in Review

OEP Capital Advisors held its AdaptHealth (AHCO) position steady in Q2 2026 at 16,312,698 shares worth $170M. The position accounts for 100% of the portfolio, ranked #1.

OEP Capital Advisors first reported a position in AHCO in Q4 2020 and has held it in 23 quarters since. The position peaked at $519M in Q4 2020. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • OEP Capital Advisors held 16,312,698 shares of AdaptHealth worth $170M as of Q2 2026.
  • OEP Capital Advisors left its AdaptHealth share count unchanged in Q2 2026.
  • AdaptHealth made up 100% of OEP Capital Advisors's portfolio in Q2 2026, its #1 holding.
  • OEP Capital Advisors first reported a position in AdaptHealth in Q4 2020 and has held it in 23 quarters since.
  • OEP Capital Advisors's AdaptHealth position peaked at $519M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on OEP Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.